First Time Loading...
R

Redx Pharma PLC
LSE:REDX

Watchlist Manager
Redx Pharma PLC
LSE:REDX
Watchlist
Price: 15 GBX 31.58%
Updated: May 7, 2024

Redx Pharma PLC
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Redx Pharma PLC
Net Income (Common) Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
R
Redx Pharma PLC
LSE:REDX
Net Income (Common)
-£33.2m
CAGR 3-Years
-53%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Net Income (Common)
£4.5B
CAGR 3-Years
-5%
CAGR 5-Years
3%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Net Income (Common)
$6.3B
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
12%
Indivior PLC
LSE:INDV
Net Income (Common)
$5m
CAGR 3-Years
-63%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Net Income (Common)
$190m
CAGR 3-Years
-24%
CAGR 5-Years
-8%
CAGR 10-Years
-1%
Dechra Pharmaceuticals PLC
LSE:DPH
Net Income (Common)
-£27.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Redx Pharma PLC's Net Income (Common)?
Net Income (Common)
-33.2m GBP

Based on the financial report for Sep 30, 2023, Redx Pharma PLC's Net Income (Common) amounts to -33.2m GBP.

What is Redx Pharma PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-30%

Over the last year, the Net Income (Common) growth was -84%. The average annual Net Income (Common) growth rates for Redx Pharma PLC have been -53% over the past three years , -30% over the past five years .